<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05061680</url>
  </required_header>
  <id_info>
    <org_study_id>Largeballoon dilation</org_study_id>
    <nct_id>NCT05061680</nct_id>
  </id_info>
  <brief_title>Quick Large Balloon Dilatation for Removal of Large Bile Duct Stones (SHODBADI)</brief_title>
  <acronym>SHODBADI</acronym>
  <official_title>Endoscopic Papillary Short Duration Large Balloon Dilatation for Removal of Large Bile Duct Stones: a Prospective Multicenter Study of Short and Long-term Adverse Events</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Helsinki University Central Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Helsinki University Central Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      ESGE guidelines suggests 30-60 seconds endoscopic large balloon papillary dilation from the&#xD;
      disappearance of the waist of the papilla.&#xD;
&#xD;
      The investigators have good results in stone removal with much quicker dilatations when the&#xD;
      cholangiogram is followed and the dilation is finished as soon as the disappearance of the&#xD;
      waist of the papilla is seen. This Scandinavian multicenter prospective study is especially&#xD;
      interested in stone clearance rate and short and long-term adverse events such as&#xD;
      pancreatitis, cholangitis, bleeding, perforations, residual biliary stones, and newly&#xD;
      developing biliary stones.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study is planned as a multicenter Scandinavian prospective study including all the&#xD;
      patients &gt;18 years with &gt;10mm diameter common bile duct stones visible in cholangiogram.&#xD;
      Before ERCP all patient will be informed about this trial, and if they agree to participate&#xD;
      this study, they need to give a written informed consent. The endoscopists will decide&#xD;
      whether the first step will be large EST and stone extraction or small EST and dilatation. If&#xD;
      simple EST does not success, the dilatation will remain as a rescue method. The diameter of&#xD;
      dilatation balloon cannot exceed the diameter of common bile duct above the papilla.&#xD;
      Cholangiogram is followed when papilla is dilated and the dilatation will be ended when the&#xD;
      waist of the papilla disappears. The duration of the dilatation measured, but it does not&#xD;
      define the ending of dilatation. All adverse events will be recorded one month and a year&#xD;
      after the procedure.&#xD;
&#xD;
      Classification of the patients:&#xD;
&#xD;
        1. EST and stone extraction&#xD;
&#xD;
        2. EPLBD when EST and stone extraction did not succeed&#xD;
&#xD;
        3. Short EST and EPLBD&#xD;
&#xD;
      The investigators will collect the information of adverse events such as bleeding,&#xD;
      pancreatitis, cholangitis with patient questionnaire as well as from the patient records one&#xD;
      month and a year after the procedure&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">April 5, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Rate of bleeding</measure>
    <time_frame>30 days</time_frame>
    <description>need for additional intervention or need for blood transfusion and hemoglobin drop more than 2 gm/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of pancreatitis</measure>
    <time_frame>30 days</time_frame>
    <description>Plasma amylase rises &gt;3 times the upper limit and newly developed stomach ace more than 24h</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Rate of cholangitis</measure>
    <time_frame>30 days</time_frame>
    <description>Fever &gt;38</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">600</enrollment>
  <condition>Pancreatitis, Acute</condition>
  <condition>Bleeding</condition>
  <condition>Cholangitis</condition>
  <arm_group>
    <arm_group_label>short sphincterotomy +Short duration papillary large balloon dilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with short sphincterotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>full sphincterotomy + short duration papillary balloon dilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with full lenght sphincterotomy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>previous sphincterotomy + short duration papillary balloon dilation</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with previous sphincterotomy</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>endoscopic short duration papillary large balloon dilation</intervention_name>
    <description>During the large balloon papillary dilation investigators follow the cholangiogram and stop the dilatation as soon as the disappearance of the waist of the papilla is noticed.</description>
    <arm_group_label>full sphincterotomy + short duration papillary balloon dilation</arm_group_label>
    <arm_group_label>previous sphincterotomy + short duration papillary balloon dilation</arm_group_label>
    <arm_group_label>short sphincterotomy +Short duration papillary large balloon dilation</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Age &gt;18 years&#xD;
&#xD;
          -  Common bile duct stone &gt;10mm diameter&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Altered anatomy after surgery (B II, Roux-en-Y reconstruction)&#xD;
&#xD;
          -  Common bile duct cysts&#xD;
&#xD;
          -  Acute pancreatitis&#xD;
&#xD;
          -  Distal common bile duct stricture or tumor&#xD;
&#xD;
          -  Coagulation disorders&#xD;
&#xD;
          -  Ongoing coagulation medication&#xD;
&#xD;
          -  Pregnancy&#xD;
&#xD;
          -  Inability to give an informed consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>95 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Mia Rainio, Md, PhD</last_name>
    <role>Study Director</role>
    <affiliation>Helsinki University Central Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Mia Rainio, MD, PhD</last_name>
    <phone>+358505833060</phone>
    <email>mia.rainio@hus.fi</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Leena Kylänpää, MD, PhD</last_name>
    <phone>+35894711</phone>
    <email>leena.kylanpaa@hus.fi</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Helsinki University Hospital</name>
      <address>
        <city>Helsinki</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Mia Rainio, MD, PhD</last_name>
      <phone>+358505833060</phone>
      <email>mia.rainio@hus.fi</email>
    </contact>
    <contact_backup>
      <last_name>Leena Kylänpää, Md PhD</last_name>
      <phone>+35894711</phone>
      <email>leena.kylanpaa@hus.fi</email>
    </contact_backup>
  </location>
  <location>
    <facility>
      <name>Turku University Hospital</name>
      <address>
        <city>Turku</city>
        <country>Finland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Juha Grönroos, Professor</last_name>
      <phone>+358 2 3130000</phone>
      <email>juha.gronroos@tyks.fi</email>
    </contact>
  </location>
  <location_countries>
    <country>Finland</country>
  </location_countries>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>September 20, 2021</study_first_submitted>
  <study_first_submitted_qc>September 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2021</study_first_posted>
  <last_update_submitted>October 12, 2021</last_update_submitted>
  <last_update_submitted_qc>October 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 19, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Helsinki University Central Hospital</investigator_affiliation>
    <investigator_full_name>Mia Rainio</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pancreatitis</mesh_term>
    <mesh_term>Cholangitis</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

